This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
amino acid | 3195 |
amino acids | 2413 |
respiratory syndrome | 1510 |
infected cells | 1333 |
acute respiratory | 1296 |
gene expression | 1242 |
cell lines | 1241 |
severe acute | 1216 |
immune response | 1213 |
spike protein | 1197 |
mass spectrometry | 1169 |
cell surface | 1073 |
plasma membrane | 1049 |
viral proteins | 1041 |
host cell | 981 |
endoplasmic reticulum | 952 |
protein interactions | 949 |
syndrome coronavirus | 896 |
cell line | 862 |
binding protein | 854 |
membrane proteins | 852 |
virus infection | 824 |
viral replication | 810 |
membrane protein | 791 |
cell death | 786 |
binding site | 755 |
immune responses | 737 |
class i | 732 |
protein expression | 726 |
viral rna | 710 |
type i | 703 |
influenza virus | 692 |
protein synthesis | 691 |
escherichia coli | 679 |
virus replication | 667 |
nucleocapsid protein | 662 |
immune system | 652 |
present study | 641 |
important role | 640 |
structural proteins | 637 |
cancer cells | 633 |
western blot | 630 |
protein interaction | 629 |
secondary structure | 626 |
rna viruses | 626 |
binding sites | 620 |
fusion protein | 611 |
cell culture | 608 |
cell cycle | 604 |
membrane fusion | 602 |
sars coronavirus | 601 |
extracellular vesicles | 595 |
molecular dynamics | 589 |
protein structure | 587 |
growth factor | 578 |
oxidative stress | 568 |
summary conclusion | 561 |
acid residues | 557 |
virus type | 556 |
breast cancer | 545 |
crystal structure | 543 |
innate immune | 542 |
doc id | 541 |
cord uid | 541 |
molecular weight | 533 |
protein kinase | 525 |
electron microscopy | 519 |
viral infection | 518 |
flow cytometry | 500 |
epithelial cells | 496 |
binding domain | 495 |
binding proteins | 491 |
host cells | 488 |
fusion proteins | 488 |
host proteins | 485 |
mammalian cells | 485 |
rna polymerase | 477 |
wild type | 477 |
herpes simplex | 471 |
immunodeficiency virus | 469 |
heat shock | 469 |
transcription factor | 463 |
nervous system | 460 |
class ii | 459 |
active site | 454 |
simplex virus | 446 |
drug discovery | 443 |
protein sequences | 443 |
recombinant proteins | 434 |
recombinant protein | 432 |
viral protein | 431 |
protein folding | 430 |
monoclonal antibodies | 429 |
cell types | 428 |
human immunodeficiency | 428 |
stem cells | 426 |
cell proliferation | 425 |
acid sequence | 424 |
novel coronavirus | 423 |
ms ms | 421 |
results suggest | 420 |
vaccinia virus | 415 |
mg kg | 413 |
nucleic acid | 406 |
conformational changes | 396 |
envelope protein | 392 |
terminal domain | 392 |
highly conserved | 389 |
protein complexes | 389 |
molecular mechanisms | 384 |
may also | 382 |
performed using | 380 |
protein sequence | 378 |
two different | 377 |
capsid protein | 377 |
endothelial cells | 376 |
signal transduction | 374 |
transcription factors | 374 |
disease virus | 370 |
dengue virus | 364 |
expression levels | 364 |
target protein | 362 |
binding affinity | 360 |
mg ml | 358 |
cell membrane | 357 |
dependent manner | 352 |
spike glycoprotein | 349 |
mhc class | 349 |
wide range | 349 |
golgi apparatus | 348 |
rna synthesis | 347 |
drug delivery | 347 |
open reading | 344 |
stranded rna | 341 |
small molecules | 341 |
human proteins | 339 |
proteomic analysis | 338 |
dendritic cells | 338 |
secretory pathway | 337 |
intrinsically disordered | 336 |
protein structures | 336 |
virus entry | 333 |
mosaic virus | 333 |
dna damage | 333 |
differentially expressed | 333 |
life cycle | 332 |
lipid bilayer | 332 |
like particles | 331 |
cancer cell | 330 |
clinical trials | 327 |
signaling pathways | 322 |
coronavirus spike | 321 |
sialic acid | 320 |
viral genome | 320 |
cellular proteins | 319 |
proteins involved | 319 |
gel electrophoresis | 319 |
room temperature | 319 |
free energy | 315 |
western blotting | 314 |
monoclonal antibody | 313 |
innate immunity | 312 |
control group | 312 |
bone marrow | 311 |
acid composition | 310 |
transmembrane domain | 310 |
results indicate | 309 |
widely used | 308 |
receptor binding | 306 |
infectious bronchitis | 305 |
structural protein | 304 |
translation initiation | 302 |
previous studies | 302 |
phage display | 301 |
ion channel | 301 |
central nervous | 299 |
tumor cells | 294 |
cell epitopes | 293 |
cell growth | 293 |
large number | 291 |
biological activity | 291 |
nucleic acids | 289 |
er stress | 289 |
hepatitis virus | 288 |
results showed | 287 |
protease inhibitors | 285 |
also known | 284 |
signaling pathway | 283 |
reading frame | 282 |
protein production | 279 |
vaccine development | 278 |
bronchitis virus | 278 |
target proteins | 278 |
protein binding | 276 |
results show | 274 |
protein complex | 273 |
molecular biology | 273 |
intrinsic disorder | 272 |
small molecule | 272 |
closely related | 271 |
drug design | 271 |
high affinity | 271 |
prostate cancer | 271 |
signal peptide | 270 |
type ii | 269 |
hela cells | 268 |
commonly used | 268 |
spinal cord | 267 |
data suggest | 267 |
high levels | 267 |
porcine epidemic | 266 |
host factors | 266 |
cellular processes | 266 |
taken together | 265 |
viral infections | 265 |
cells expressing | 264 |
host protein | 262 |
quality control | 262 |
middle east | 260 |
subcellular localization | 260 |
blot analysis | 259 |
cleavage site | 258 |
stem cell | 257 |
acid sequences | 257 |
nmr spectroscopy | 255 |
cells infected | 254 |
terminal region | 252 |
ion channels | 252 |
recent studies | 251 |
expression system | 250 |
ng ml | 250 |
shock protein | 250 |
strand rna | 249 |
infectious diseases | 249 |
neutralizing antibodies | 248 |
mouse hepatitis | 248 |
previously described | 248 |
rna binding | 247 |
rna replication | 247 |
disulfide bonds | 247 |
converting enzyme | 246 |
also found | 245 |
saccharomyces cerevisiae | 244 |
key role | 244 |
epidemic diarrhea | 242 |
east respiratory | 242 |
transgenic mice | 242 |
ligand binding | 241 |
significantly higher | 240 |
protein microarrays | 240 |
rna virus | 240 |
fatty acids | 238 |
human coronavirus | 238 |
target cells | 237 |
reactive oxygen | 237 |
viral entry | 236 |
protein function | 236 |
two proteins | 236 |
mouse model | 236 |
first time | 236 |
dynamics simulations | 235 |
cell entry | 234 |
fatty acid | 233 |
virtual screening | 233 |
different types | 233 |
living cells | 232 |
like protein | 231 |
sequence analysis | 231 |
nucleotide sequence | 231 |
spike proteins | 231 |
lung cancer | 231 |
liquid chromatography | 231 |
outer membrane | 231 |
associated protein | 231 |
protein levels | 230 |
diarrhea virus | 230 |
cell adhesion | 229 |
antigen presentation | 229 |
vesicular stomatitis | 228 |
glutamic acid | 227 |
side chains | 227 |
specific antibodies | 226 |
proteins may | 226 |
respiratory syncytial | 226 |
sequence similarity | 225 |
mm tris | 224 |
oxygen species | 223 |
fluorescent protein | 223 |
virus particles | 222 |
peripheral blood | 222 |
side chain | 222 |
golgi complex | 222 |
cytoplasmic domain | 220 |
cell viability | 220 |
syncytial virus | 219 |
host immune | 219 |
structural basis | 218 |
human protein | 217 |
core protein | 217 |
enveloped viruses | 217 |
viral envelope | 215 |
cell responses | 215 |
analysis revealed | 214 |
viral particles | 214 |
dna replication | 212 |
human cells | 212 |
signal sequence | 211 |
expression level | 211 |
ns protein | 211 |
side effects | 211 |
sequence alignment | 210 |
animal models | 209 |
human cytomegalovirus | 209 |
stress response | 209 |
cell type | 208 |
orf protein | 208 |
nonstructural protein | 208 |
coronavirus nucleocapsid | 208 |
crucial role | 208 |
mrna expression | 207 |
stomatitis virus | 207 |
cell cultures | 207 |
gene products | 206 |
cancer patients | 206 |
fever virus | 205 |
three different | 205 |
drug development | 205 |
serine protease | 204 |
extracellular matrix | 203 |
recent years | 203 |
er membrane | 202 |
kda protein | 202 |
disordered proteins | 201 |
structure prediction | 200 |
solid phase | 200 |
serum albumin | 199 |
nuclear export | 198 |
initiation factor | 198 |
deficient mice | 198 |
ebola virus | 198 |
force field | 197 |
high throughput | 197 |
cell activation | 196 |
fusion peptide | 195 |
molecular docking | 195 |
results obtained | 194 |
lipid bilayers | 194 |
also observed | 194 |
serum samples | 194 |
tof ms | 193 |
translational modifications | 193 |
genomic rna | 193 |
antimicrobial peptides | 192 |
significantly increased | 191 |
ubiquitin ligase | 191 |
reading frames | 191 |
drug targets | 191 |
capsid proteins | 190 |
immune cells | 190 |
human sars | 190 |
inflammatory response | 189 |
cell receptor | 189 |
neurodegenerative diseases | 188 |
barr virus | 188 |
first step | 188 |
conformational change | 188 |
negatively charged | 188 |
expression vector | 188 |
like receptor | 187 |
associated proteins | 187 |
integral membrane | 187 |
experimental data | 187 |
dna binding | 187 |
surfactant protein | 187 |
critical role | 186 |
culture medium | 185 |
envelope proteins | 185 |
biological processes | 185 |
may play | 185 |
channel activity | 185 |
even though | 185 |
gene therapy | 184 |
may contribute | 183 |
blood samples | 182 |
three times | 182 |
significantly reduced | 181 |
eukaryotic cells | 181 |
sars cov | 181 |
mouth disease | 181 |
cd cd | 180 |
commercially available | 180 |
viral dna | 180 |
cytoplasmic tail | 179 |
takes place | 179 |
tandem mass | 178 |
smooth muscle | 178 |
expression systems | 178 |
insect cells | 178 |
positively charged | 178 |
nuclear localization | 177 |
activated protein | 176 |
like protease | 175 |
biologically active | 175 |
least one | 175 |
enzyme activity | 174 |
multiple sclerosis | 174 |
envelope glycoprotein | 174 |
two distinct | 174 |
cell lysates | 173 |
enzymatic activity | 173 |
cysteine residues | 172 |
better understanding | 172 |
affinity chromatography | 172 |
molecular mass | 172 |
ray crystallography | 172 |
protein vi | 171 |
sequence identity | 171 |
nitric oxide | 171 |
cell fusion | 171 |
significant differences | 171 |
peptide synthesis | 171 |
factor receptor | 170 |
crystal structures | 170 |
dna polymerase | 170 |
significant difference | 170 |
virus rna | 170 |
skeletal muscle | 169 |
high level | 168 |
tyrosine kinase | 168 |
semliki forest | 168 |
antiviral activity | 168 |
determined using | 168 |
statistically significant | 168 |
hydrogen bonds | 168 |
protein degradation | 168 |
coat protein | 168 |
bovine serum | 167 |
antibody response | 167 |
tertiary structure | 167 |
healthy controls | 167 |
expressed proteins | 166 |
protein data | 166 |
dependent rna | 166 |
may provide | 166 |
matrix protein | 165 |
disulfide bond | 165 |
determine whether | 165 |
protein identification | 165 |
protease inhibitor | 165 |
circular dichroism | 165 |
transmissible gastroenteritis | 165 |
human plasma | 165 |
well known | 164 |
data bank | 164 |
kcal mol | 164 |
complex formation | 163 |
type iii | 163 |
structural information | 162 |
forest virus | 162 |
reverse transcriptase | 162 |
significant increase | 162 |
molecular mechanism | 161 |
exclusion chromatography | 161 |
vaccine candidates | 161 |
interaction networks | 160 |
supplementary table | 160 |
cell survival | 160 |
protein may | 159 |
time points | 159 |
hepatocellular carcinoma | 159 |
confocal microscopy | 159 |
tumor suppressor | 159 |
cell biology | 159 |
gene product | 159 |
vaccine construct | 159 |
total protein | 159 |
molecular basis | 158 |
secretory proteins | 158 |
human diseases | 158 |
web server | 158 |
recent study | 157 |
necrosis factor | 157 |
human serum | 157 |
dna sequences | 157 |
surface expression | 157 |
dna viruses | 157 |
magnetic resonance | 156 |
derived evs | 156 |
epidermal growth | 156 |
related protein | 156 |
nonstructural proteins | 155 |
induced apoptosis | 155 |
transfected cells | 155 |
unfolded protein | 155 |
hek cells | 155 |
united states | 154 |
transmission electron | 154 |
analysis showed | 154 |
cell wall | 154 |
i interferon | 153 |
cells using | 153 |
antiviral response | 153 |
protein families | 153 |
nuclear import | 153 |
coronavirus disease | 153 |
zika virus | 152 |
gene encoding | 152 |
viral membrane | 152 |
full length | 152 |
affi nity | 151 |
present work | 151 |
synthetic peptides | 151 |
autoimmune diseases | 150 |
rss gfp | 150 |
poorly understood | 150 |
adaptive immune | 150 |
also used | 150 |
genome sequence | 150 |
mm nacl | 150 |
shock proteins | 150 |
cell membranes | 150 |
inflammatory cytokines | 150 |
studies showed | 150 |
data indicate | 150 |
proteins identified | 149 |
biological functions | 149 |
ex vivo | 149 |
membrane vesicles | 149 |
functional analysis | 148 |
structural analysis | 148 |
protein concentration | 148 |
van der | 148 |
inhibitory activity | 148 |
protein microarray | 148 |
human papillomavirus | 148 |
light scattering | 148 |
mammalian cell | 148 |
essential role | 148 |
results demonstrate | 147 |
sars patients | 147 |
transmembrane protein | 147 |
accessory proteins | 147 |
nanoparticle tracking | 146 |
related proteins | 146 |
physicochemical properties | 146 |
based vaccines | 146 |
tracking analysis | 145 |
molecular interactions | 145 |
plasmid dna | 145 |
transgenic plants | 145 |
different cell | 145 |
virus assembly | 145 |
protein spots | 145 |
real time | 144 |
antibody responses | 144 |
electrostatic interactions | 144 |
protein family | 144 |
tumor cell | 144 |
binding pocket | 144 |
aug codon | 144 |
structural features | 143 |
golgi network | 143 |
reverse transcription | 143 |
family members | 142 |
viral mrnas | 142 |
negative control | 142 |
described previously | 141 |
muscle cells | 141 |
different proteins | 141 |
cleavage sites | 141 |
ge healthcare | 141 |
proteins using | 141 |
time pcr | 141 |
antimicrobial activity | 140 |
blood pressure | 140 |
vero cells | 140 |
central role | 140 |
dimensional structure | 140 |
previously reported | 140 |
directed mutagenesis | 140 |
protein level | 140 |
nuclear pore | 139 |
ms analysis | 139 |
may lead | 139 |
pdb id | 139 |
human genome | 139 |
schwann cells | 139 |
inhibitory effect | 139 |
binding domains | 138 |
body weight | 138 |
growth factors | 138 |
fluorescence microscopy | 138 |
transmembrane proteins | 137 |
interaction network | 137 |
model system | 137 |
analysis using | 137 |
based drug | 137 |
size exclusion | 137 |
cov infection | 136 |
rheumatoid arthritis | 136 |
protein response | 136 |
important roles | 136 |
rna genome | 136 |
high resolution | 136 |
subunit vaccine | 136 |
authors declare | 136 |
coronavirus replication | 135 |
substrate specificity | 135 |
newly synthesized | 135 |
multiple sequence | 135 |
like receptors | 134 |
graphical representation | 134 |
potential therapeutic | 134 |
recent advances | 134 |
new insights | 134 |
tumor necrosis | 134 |
least two | 134 |
light chain | 134 |
glial cells | 134 |
dna repair | 133 |
naturally occurring | 133 |
delivery systems | 133 |
nucleolar localization | 133 |
gene transfer | 133 |
lipid rafts | 133 |
analyzed using | 133 |
structural studies | 133 |
data show | 132 |
single molecule | 132 |
public health | 132 |
data analysis | 132 |
surface proteins | 132 |
human proteome | 132 |
genes encoding | 132 |
heart failure | 132 |
i ifn | 131 |
fold increase | 131 |
clinical trial | 131 |
two groups | 131 |
host interactions | 131 |
mrna levels | 131 |
current study | 131 |
containing proteins | 131 |
building blocks | 130 |
murine coronavirus | 130 |
gene delivery | 130 |
heavy chain | 130 |
gene ontology | 130 |
ribosomal proteins | 130 |
major role | 130 |
using different | 130 |
i mhc | 130 |
goat anti | 130 |
nsp protein | 129 |
structural changes | 129 |
leukemia virus | 129 |
cell signaling | 129 |
replication complex | 129 |
infected cell | 128 |
plasma samples | 128 |
cholera toxin | 128 |
target cell | 128 |
cultured cells | 127 |
dna sequence | 127 |
based methods | 127 |
signalling pathways | 127 |
bat cov | 127 |
low molecular | 127 |
rabies virus | 127 |
machine learning | 126 |
early stage | 126 |
heparan sulfate | 126 |
vaccine design | 126 |
findings suggest | 126 |
proteolytic cleavage | 126 |
stranded dna | 126 |
cell migration | 126 |
fold higher | 126 |
statistical analysis | 126 |
green fluorescent | 125 |
chaperone activity | 125 |
mitochondrial membrane | 125 |
synthetic peptide | 125 |
cytokine production | 125 |
glycosylation sites | 124 |
protein aggregates | 124 |
protein expressed | 124 |
west nile | 124 |
filamentous phage | 124 |
disordered regions | 124 |
major histocompatibility | 124 |
take place | 124 |
respiratory tract | 124 |
measles virus | 123 |
cell division | 123 |
protective immunity | 123 |
type diabetes | 123 |
primary structure | 123 |
cellular functions | 123 |
rna interference | 123 |
cellular protein | 123 |
throughput screening | 123 |
virus envelope | 123 |
catalytic activity | 122 |
significantly lower | 122 |
coupled receptors | 122 |
replication cycle | 122 |
binding activity | 121 |
early stages | 121 |
pseudo amino | 121 |
energy transfer | 121 |
brain barrier | 121 |
like proteins | 121 |
molecular level | 121 |
specific protein | 121 |
coronavirus envelope | 121 |
total number | 121 |
transient expression | 121 |
drug resistance | 121 |
rna chaperone | 121 |
specific binding | 121 |
ovarian cancer | 121 |
sequence homology | 121 |
large scale | 120 |
surface protein | 120 |
translational modification | 120 |
coronavirus infection | 120 |
phylogenetic analysis | 120 |
associated coronavirus | 120 |
staphylococcus aureus | 120 |
physiological conditions | 120 |
blood cells | 120 |
potential role | 119 |
secondary structures | 119 |
molecular modeling | 119 |
cho cells | 119 |
virus ns | 119 |
high degree | 119 |
protein domains | 118 |
wide variety | 118 |
membrane potential | 118 |
acute phase | 118 |
water molecules | 118 |
protein stability | 118 |
increased expression | 118 |
two types | 118 |
cov nsp | 118 |
binding properties | 118 |
secretory granules | 118 |
polyacrylamide gel | 118 |
several studies | 118 |
md simulations | 117 |
yeast two | 117 |
genome replication | 117 |
low ph | 117 |
previous study | 117 |
cells treated | 117 |
cell response | 117 |
previously shown | 117 |
therapeutic target | 117 |
interacting proteins | 116 |
viral gene | 116 |
genomic dna | 116 |
viral fusion | 116 |
highly expressed | 116 |
cell epitope | 116 |
mesenchymal stem | 116 |
nuclear magnetic | 116 |
proteolytic processing | 116 |
growth hormone | 116 |
virus proteins | 116 |
identified proteins | 116 |
atpase activity | 115 |
whole blood | 115 |
may serve | 115 |
bond formation | 115 |
charged residues | 115 |
disease progression | 115 |
binding motif | 114 |
virus genome | 114 |
differential expression | 114 |
quantitative analysis | 114 |
specific proteins | 114 |
surface area | 114 |
human ace | 114 |
protein kinases | 114 |
free protein | 114 |
peptide sequences | 114 |
encephalitis virus | 113 |
risk factors | 113 |
transmembrane domains | 113 |
vaccine candidate | 113 |
ftir spectroscopy | 113 |
regulated proteins | 113 |
lipid membranes | 113 |
immune evasion | 113 |
molecular recognition | 113 |
mycobacterium tuberculosis | 112 |
dna vaccine | 112 |
systems biology | 112 |
thermo fisher | 112 |
also showed | 112 |
neutralizing antibody | 112 |
will also | 112 |
plant viruses | 111 |
untranslated region | 111 |
proteasomal degradation | 111 |
target genes | 111 |
negative bacteria | 111 |
histocompatibility complex | 111 |
knockout mice | 111 |
cystic fibrosis | 111 |
hydrogen bonding | 111 |
significantly decreased | 111 |
polypeptide chain | 111 |
main protease | 111 |
soluble protein | 111 |
syndrome virus | 111 |
new coronavirus | 111 |
disulfide isomerase | 110 |
protein content | 110 |
coding sequence | 110 |
sindbis virus | 110 |
posttranslational modifications | 110 |
may represent | 110 |
data sets | 110 |
coronavirus infectious | 109 |
fi rst | 109 |
epithelial cell | 109 |
many different | 109 |
protein gene | 109 |
many viruses | 109 |
cells transfected | 109 |
additional file | 109 |
parathyroid hormone | 109 |
quantitative proteomics | 109 |
single cell | 109 |
host defense | 109 |
binding partners | 109 |
cerebrospinal fluid | 109 |
alternative splicing | 108 |
catalytic domain | 108 |
homology modeling | 108 |
hemorrhagic fever | 108 |
arabidopsis thaliana | 108 |
porcine circovirus | 108 |
highly specific | 108 |
hcv core | 108 |
elongation factor | 108 |
mass spectrometric | 107 |
several proteins | 107 |
serine proteases | 107 |
protein engineering | 107 |
therapeutic targets | 107 |
also shown | 107 |
lipid composition | 107 |
genetic engineering | 107 |
studies using | 107 |
therapeutic potential | 106 |
acid residue | 106 |
allowed us | 106 |
protein disulfide | 106 |
mechanisms underlying | 106 |
measured using | 106 |
comparative analysis | 106 |
virus protein | 106 |
chain reaction | 106 |
particle size | 106 |
soluble proteins | 106 |
colorectal cancer | 106 |
endothelial cell | 106 |
programmed cell | 106 |
may help | 106 |
cancer therapy | 105 |
newcastle disease | 105 |
atomic force | 105 |
cell differentiation | 105 |
much higher | 105 |
protein aggregation | 105 |
epitope mapping | 105 |
human respiratory | 105 |
mass spectrometer | 105 |
biological function | 105 |
total rna | 105 |
protein molecules | 105 |
positive control | 105 |
linked glycosylation | 105 |
surface receptors | 105 |
red blood | 105 |
coupled receptor | 105 |
microglial cells | 105 |
cd cells | 105 |
terminal amino | 104 |
nile virus | 104 |
induced cell | 104 |
mast cells | 104 |
lymph nodes | 104 |
disordered protein | 104 |
i molecules | 104 |
diabetes mellitus | 104 |
protein targets | 104 |
cov spike | 103 |
proteins encoded | 103 |
affinity purification | 103 |
treated cells | 103 |
recombinant human | 103 |
direct interaction | 103 |
gastroenteritis virus | 103 |
tissue culture | 103 |
proteome analysis | 103 |
cells showed | 103 |
nucleolar proteins | 103 |
mononuclear cells | 102 |
expression patterns | 102 |
may affect | 102 |
plasmodium falciparum | 102 |
animal model | 102 |
inflammatory responses | 102 |
acid binding | 102 |
therapeutic strategies | 102 |
viral capsid | 102 |
proteins associated | 102 |
presenting cells | 102 |
neural network | 102 |
viral genomes | 102 |
swine fever | 102 |
cell density | 102 |
based approach | 101 |
culture media | 101 |
wound healing | 101 |
surface antigen | 101 |
viral life | 101 |
dependent protein | 101 |
protein interacts | 101 |
plasma protein | 101 |
high density | 101 |
remains unclear | 101 |
stress granules | 100 |
surface plasmon | 100 |
angiotensin ii | 100 |
evidence suggests | 100 |
polymerase chain | 100 |
start codon | 100 |
small intestine | 100 |
protein docking | 100 |
point mutations | 100 |
lactic acid | 100 |
drug target | 100 |
peptide sequence | 100 |
may result | 100 |
phase i | 100 |
ribosomal protein | 100 |
large amounts | 100 |
pivotal role | 99 |
play important | 99 |
expression vectors | 99 |
plasma proteins | 99 |
drug repurposing | 99 |
yeast cells | 99 |
sialic acids | 99 |
data obtained | 99 |
protease activity | 99 |
therapeutic agents | 99 |
significantly different | 99 |
infectious disease | 99 |
using two | 99 |
future studies | 99 |
functional characterization | 98 |
adaptor protein | 98 |
synovial fluid | 98 |
pore complex | 98 |
platelet aggregation | 98 |
phosphorylation sites | 98 |
functional role | 98 |
mouse models | 98 |
rational design | 98 |
laser desorption | 98 |
similar results | 98 |
stress conditions | 98 |
hydrogen bond | 97 |
high concentrations | 97 |
localization signal | 97 |
complete genome | 97 |
cellular uptake | 97 |
movement protein | 97 |
hydrophobic residues | 97 |
proteins containing | 97 |
two main | 97 |
human health | 97 |
platelet activation | 97 |
rna helicase | 97 |
antiviral drugs | 97 |
gene silencing | 97 |
virion assembly | 97 |
protein binds | 97 |
interacting protein | 97 |
proteins expressed | 96 |
reverse vaccinology | 96 |
ubiquitin ligases | 96 |
nuclear factor | 96 |
phase peptide | 96 |
sendai virus | 96 |
better understand | 96 |
expressing cells | 96 |
low levels | 96 |
results indicated | 96 |
tof mass | 96 |
actin cytoskeleton | 95 |
plant virus | 95 |
structure determination | 95 |
will provide | 95 |
energy metabolism | 95 |
genes involved | 95 |
secondary antibody | 95 |
plasmon resonance | 95 |
virus glycoprotein | 94 |
different stages | 94 |
metal ions | 94 |
pulmonary surfactant | 94 |
mediated endocytosis | 94 |
delivery system | 94 |
inclusion bodies | 94 |
apoptotic cells | 94 |
epitope prediction | 94 |
data set | 94 |
structural biology | 94 |
another study | 94 |
binding energy | 94 |
neuronal cells | 93 |
movement proteins | 93 |
protein functions | 93 |
linked immunosorbent | 93 |
point mutation | 93 |
high sensitivity | 93 |
intracellular transport | 93 |
support vector | 93 |
pseudomonas aeruginosa | 93 |
pg ml | 93 |
potential targets | 93 |
based vaccine | 93 |
possible role | 93 |
insulin resistance | 93 |
preliminary results | 93 |
cell imaging | 93 |
basic protein | 93 |
terminal part | 93 |
tumor growth | 93 |
desorption ionization | 93 |
coronavirus nsp | 93 |
also identified | 93 |
acid glycoprotein | 93 |
different mechanisms | 93 |
specific antibody | 92 |
biomarker discovery | 92 |
whole cell | 92 |
fisher scientific | 92 |
kinase activity | 92 |
subunit vaccines | 92 |
specific cd | 92 |
individual proteins | 92 |
family proteins | 92 |
exchange chromatography | 91 |
immunosorbent assay | 91 |
pattern recognition | 91 |
force microscopy | 91 |
primary sequence | 91 |
fluorescence spectroscopy | 91 |
signal peptidase | 91 |
virus core | 91 |
progenitor cells | 91 |
structural data | 91 |
adverse effects | 91 |
binding lectin | 91 |
antigen processing | 91 |
regulatory proteins | 91 |
infected patients | 91 |
molecular cloning | 90 |
higher levels | 90 |
binding affinities | 90 |
coiled coil | 90 |
alkaline phosphatase | 90 |
leaf curl | 90 |
leaky scanning | 90 |
subcellular location | 90 |
well plates | 90 |
fluorescence intensity | 90 |
amyloid fibrils | 90 |
myocardial infarction | 90 |
alveolar macrophages | 90 |
standard deviation | 90 |
inhibitory effects | 90 |
containing protein | 90 |
molecular chaperones | 90 |
protein domain | 90 |
mrna translation | 90 |
mrna display | 89 |
control cells | 89 |
experimental evidence | 89 |
fold change | 89 |
local structures | 89 |
human lung | 89 |
dna vaccines | 89 |
cellular receptor | 89 |
structural characterization | 89 |
ko mice | 89 |
currently available | 88 |
broad spectrum | 88 |
human cell | 88 |
last years | 88 |
drug binding | 88 |
proteasome system | 88 |
mechanisms involved | 88 |
rna molecules | 88 |
ribosome entry | 88 |
state nmr | 88 |
time point | 88 |
hiv infection | 88 |
modifi ed | 88 |
peptides derived | 88 |
zinc finger | 88 |
human disease | 88 |
also called | 88 |
vitro studies | 87 |
also involved | 87 |
two major | 87 |
internal ribosome | 87 |
protective effect | 87 |
coat proteins | 87 |
protein concentrations | 87 |
dynamics simulation | 87 |
see table | 87 |
protein translation | 87 |
der waals | 87 |
cysteine residue | 87 |
endocytic pathway | 87 |
virus infections | 86 |
proteolytic activity | 86 |
entry site | 86 |
among others | 86 |
located within | 86 |
potential target | 86 |
tumour cells | 86 |
calculated using | 86 |
protein encoded | 86 |
virulence factors | 86 |
cysteine proteases | 86 |
lysine residues | 86 |
eif gi | 86 |
sense rna | 86 |
plant cells | 86 |
gastrointestinal tract | 86 |
close proximity | 86 |
may cause | 85 |
vascular endothelial | 85 |
factor viii | 85 |
identifi ed | 85 |
conserved among | 85 |
long term | 85 |
extracellular vesicle | 85 |
misfolded proteins | 85 |
world health | 85 |
humoral immune | 85 |
heat stress | 85 |
computational methods | 85 |
serum proteins | 85 |
rat brain | 85 |
adaptive immunity | 85 |
protein contains | 85 |
pathogen interactions | 85 |
coding region | 84 |
ca i | 84 |
hsp inhibitors | 84 |
binding free | 84 |
contains two | 84 |
increased levels | 84 |
colon cancer | 84 |
clinical studies | 84 |
drug candidates | 84 |
influenza viruses | 84 |
natural products | 84 |
signal peptides | 84 |
superoxide dismutase | 84 |
broad range | 84 |
terminal half | 84 |
studies will | 84 |
consensus sequence | 84 |
group i | 84 |
vp protein | 84 |
biological systems | 84 |
also present | 84 |
health organization | 84 |
selective autophagy | 84 |
eukaryotic translation | 83 |
identified using | 83 |
different species | 83 |
reporter gene | 83 |
plasminogen activator | 83 |
virulence factor | 83 |
disulfide bridges | 83 |
protein structural | 83 |
gene transcription | 83 |
fully understood | 83 |
respiratory distress | 83 |
rna processing | 83 |
active sites | 83 |
adipose tissue | 83 |
risk factor | 83 |
investigated using | 83 |
nkt cells | 83 |
biomedical applications | 83 |
dna synthesis | 83 |
highly sensitive | 83 |
intracellular localization | 83 |
will help | 83 |
cell function | 83 |
autophagosome formation | 83 |
generated using | 82 |
virus fusion | 82 |
ligand interactions | 82 |
respiratory disease | 82 |
ii fusion | 82 |
several different | 82 |
give rise | 82 |
studies suggest | 82 |
protein purification | 82 |
cycle progression | 82 |
chemical synthesis | 82 |
signalling pathway | 82 |
lipid membrane | 82 |
viral glycoproteins | 82 |
insect cell | 82 |
size distribution | 82 |
three groups | 82 |
hydrophobic interactions | 82 |
live cells | 82 |
limited number | 82 |
protein surface | 82 |
drosophila melanogaster | 82 |
based protein | 82 |
host range | 81 |
related genes | 81 |
many proteins | 81 |
proteins including | 81 |
secreted proteins | 81 |
resonance energy | 81 |
usa introduction | 81 |
cysteine protease | 81 |
distantly related | 81 |
coronavirus associated | 81 |
human coronaviruses | 81 |
target gene | 81 |
genome sequences | 81 |
virus capsid | 81 |
single amino | 81 |
mammary gland | 81 |
sample preparation | 81 |
protein secondary | 81 |
overlapping genes | 81 |
time course | 81 |
therapeutic proteins | 81 |
late endosomes | 81 |
transcriptional regulation | 80 |
scoring function | 80 |
small number | 80 |
obtained using | 80 |
lipid droplets | 80 |
steady state | 80 |
might also | 80 |
cell population | 80 |
ace receptor | 80 |
functional studies | 80 |
genetically engineered | 80 |
will allow | 80 |
hydrogen peroxide | 80 |
flow rate | 80 |
healthy subjects | 80 |
lg ml | 80 |
significant reduction | 80 |
different viruses | 80 |
antimicrobial peptide | 80 |
bioactive peptides | 80 |
virus hemagglutinin | 80 |
washed three | 80 |
fusion loop | 80 |
reticulum stress | 80 |
expression profiles | 80 |
cells via | 80 |
polymerase ii | 80 |
functional groups | 79 |
buffered saline | 79 |
experimental conditions | 79 |
proinflammatory cytokines | 79 |
well established | 79 |
studies revealed | 79 |
virus strain | 79 |
functional properties | 79 |
viral pathogenesis | 79 |
pathological conditions | 79 |
may act | 79 |
metal ion | 79 |
cell receptors | 79 |
human brain | 79 |
rna silencing | 79 |
ionic strength | 79 |
four different | 79 |
predicting protein | 79 |
proteins might | 79 |
enrichment analysis | 79 |
low concentrations | 79 |
protein nanocages | 79 |
lysis buffer | 79 |
cardiovascular disease | 79 |
potential drug | 79 |
indirect immunofluorescence | 79 |
sequence data | 78 |
tyrosine kinases | 78 |
virus nucleocapsid | 78 |
new therapeutic | 78 |
systemic lupus | 78 |
mdck cells | 78 |
protein genes | 78 |
virus particle | 78 |
cellular stress | 78 |
fluorescent proteins | 78 |
assisted laser | 78 |
fusion activity | 78 |
one hand | 78 |
structural similarity | 78 |
cellular membranes | 78 |
aug codons | 78 |
leader sequence | 78 |
mutant proteins | 78 |
significant decrease | 78 |
protein sorting | 78 |
novel therapeutic | 78 |
significant role | 78 |
inflammatory diseases | 78 |
well understood | 78 |
functional protein | 77 |
lysosomal enzymes | 77 |
simian virus | 77 |
replication complexes | 77 |
carcinoma cells | 77 |
antibody production | 77 |
envelope glycoproteins | 77 |
nuclear transport | 77 |
viral particle | 77 |
regulated secretory | 77 |
different time | 77 |
lupus erythematosus | 77 |
plasma levels | 77 |
successfully used | 77 |
primary human | 77 |
viral pathogens | 77 |
different concentrations | 77 |
interaction data | 77 |
molecular mimicry | 77 |
antibody fragments | 77 |
heterogeneous nuclear | 77 |
growth rate | 77 |
using protein | 77 |
days post | 77 |
abundant proteins | 77 |
porcine reproductive | 77 |
biological properties | 77 |
peptide binding | 77 |
expression analysis | 77 |
new approach | 77 |
bacillus subtilis | 77 |
data demonstrate | 77 |
tobacco mosaic | 77 |
natural killer | 77 |
binding region | 76 |
serum levels | 76 |
sequence alignments | 76 |
biological activities | 76 |
receptor activation | 76 |
science foundation | 76 |
cell lung | 76 |
culture supernatants | 76 |
antiviral drug | 76 |
copy number | 76 |
secreted protein | 76 |
small rna | 76 |
powerful tool | 76 |
neural networks | 76 |
poliovirus rna | 76 |
type mice | 76 |
molecular chaperone | 76 |
blood mononuclear | 76 |
life sciences | 76 |
apoptotic cell | 76 |
positive cells | 76 |
metabolic pathways | 76 |
investigate whether | 76 |
molecule inhibitors | 76 |
chinese hamster | 76 |
live cell | 76 |
vast majority | 76 |
adhesion molecules | 76 |
sequence motifs | 75 |
receptor tyrosine | 75 |
viral diseases | 75 |
containing mm | 75 |
pbs containing | 75 |
protein abundance | 75 |
igg antibodies | 75 |
single protein | 75 |
sequence information | 75 |
polyclonal antibodies | 75 |
host factor | 75 |
interaction partners | 75 |
negative regulator | 75 |
like proteinase | 75 |
peptide libraries | 75 |
protein transport | 75 |
african swine | 75 |
therapeutic intervention | 75 |
lung injury | 75 |
expression pattern | 74 |
physical properties | 74 |
terminal residues | 74 |
inflammatory cytokine | 74 |
years ago | 74 |
using anti | 74 |
solvent accessibility | 74 |
like particle | 74 |
dynamic light | 74 |
performance liquid | 74 |
well characterized | 74 |
approved drugs | 74 |
showed significant | 74 |
purifi ed | 74 |
immune cell | 74 |
lymph node | 74 |
cleavage products | 74 |
causative agent | 74 |
circovirus type | 74 |
codon usage | 74 |
membrane insertion | 74 |
shed light | 74 |
infectious virus | 74 |
cycle arrest | 74 |
protein vp | 74 |
accession number | 74 |
aspartic acid | 74 |
plant species | 74 |
another example | 74 |
messenger rna | 74 |
long time | 74 |
golgi membranes | 73 |
cells may | 73 |
also demonstrated | 73 |
high expression | 73 |
density gradient | 73 |
derived exosomes | 73 |
membrane curvature | 73 |
mm edta | 73 |
brain tissue | 73 |
amino terminus | 73 |
peptide ligands | 73 |
viral vectors | 73 |
great potential | 73 |
viral mrna | 73 |
membrane association | 73 |
chemical shift | 73 |
ic values | 73 |
thermal stability | 73 |
transduction pathways | 73 |
immunogenic proteins | 73 |
table i | 73 |
ang ii | 73 |
ubiquitin chains | 73 |
antigen presenting | 73 |
enzymes involved | 73 |
md simulation | 73 |
proteomics analysis | 73 |
cellular response | 72 |
cellular immune | 72 |
infection cycle | 72 |
helical structure | 72 |
posttranslational modification | 72 |
virus production | 72 |
pregnant women | 72 |
initiation factors | 72 |
starting point | 72 |
viral structural | 72 |
protein arrays | 72 |
mobile phase | 72 |
cell extracts | 72 |
purifi cation | 72 |
detected using | 72 |
remains unknown | 72 |
specific interaction | 72 |
nuclear envelope | 72 |
mhc molecules | 72 |
low abundance | 72 |
terminal end | 72 |
still unclear | 72 |
may occur | 72 |
adaptor proteins | 72 |
many cases | 72 |
idps idprs | 71 |
studied using | 71 |
cell populations | 71 |
myelin basic | 71 |
mechanical properties | 71 |
recognition receptors | 71 |
specifi city | 71 |
infected mice | 71 |
based method | 71 |
also able | 71 |
recipient cells | 71 |
also performed | 71 |
molecular weights | 71 |
culture supernatant | 71 |
hla class | 71 |
pancreatic cancer | 71 |
lipid metabolism | 71 |
different protein | 71 |
functional domains | 71 |
extracellular domain | 71 |
like structures | 71 |
virus release | 71 |
high performance | 71 |
significant changes | 71 |
rabbit anti | 71 |
product quality | 71 |
assessed using | 71 |
translational control | 70 |
rna pol | 70 |
creative commons | 70 |
serine threonine | 70 |
cellular pathways | 70 |
genetic material | 70 |
human blood | 70 |
coronavirus nonstructural | 70 |
class iii | 70 |
viral antigens | 70 |
derived extracellular | 70 |
multifunctional protein | 70 |
false positives | 70 |
situ hybridization | 70 |
rat liver | 70 |
white matter | 70 |
transforming growth | 70 |
times higher | 70 |
without affecting | 70 |
murine leukemia | 70 |
evaluated using | 70 |
culture conditions | 70 |
protein coupled | 70 |
effi cient | 70 |
viral rnas | 70 |
transgenic mouse | 70 |
distress syndrome | 70 |
pathway analysis | 70 |
hepg cells | 70 |
novel protein | 70 |
regulatory factor | 70 |
study showed | 70 |
conditioned medium | 70 |
nuclear ribonucleoprotein | 70 |
final concentration | 70 |
protein inhibits | 70 |
human host | 70 |
gene regulation | 70 |
host translation | 70 |
monte carlo | 70 |
previous work | 70 |
cell apoptosis | 70 |
supplementary material | 69 |
high temperature | 69 |
cardiovascular diseases | 69 |
ab initio | 69 |
associated degradation | 69 |
three proteins | 69 |
peptide bond | 69 |
binding mode | 69 |
recently reported | 69 |
nsp nsp | 69 |
force fields | 69 |
protein induces | 69 |
computational approaches | 69 |
mediated autophagy | 69 |
provide new | 69 |
vesicle formation | 69 |
current knowledge | 69 |
regulatory protein | 69 |
signaling molecules | 69 |
quaternary structure | 69 |
cdna library | 69 |
surface receptor | 69 |
may explain | 69 |
also reported | 69 |
studies indicate | 69 |
recently developed | 69 |
clinical applications | 69 |
estrogen receptor | 69 |
relatively high | 69 |
lipid peroxidation | 69 |
assay using | 68 |
hamster ovary | 68 |
statistical significance | 68 |
new method | 68 |
avian influenza | 68 |
unfolded proteins | 68 |
melanoma cells | 68 |
protein secretion | 68 |
protein analysis | 68 |
early detection | 68 |
protective immune | 68 |
structural properties | 68 |
formic acid | 68 |
pathogenic bacteria | 68 |
retention signal | 68 |
horseradish peroxidase | 68 |
high quality | 68 |
nmr studies | 68 |
will present | 68 |
kj mol | 68 |
muscular dystrophy | 68 |
eukaryotic initiation | 68 |
physiological processes | 68 |
per se | 68 |
purified protein | 68 |
cell lysate | 68 |
protein glycosylation | 67 |
elevated levels | 67 |
nuclear translocation | 67 |
hours post | 67 |
heptad repeat | 67 |
healthy donors | 67 |
free system | 67 |
buffer containing | 67 |
vascular smooth | 67 |
three dimensional | 67 |
binding capacity | 67 |
proteins within | 67 |
blood vessels | 67 |
cytoplasmic domains | 67 |
dimensional structures | 67 |
studies show | 67 |
nk cells | 67 |
vivo studies | 67 |
nuclear proteins | 67 |
blood coagulation | 67 |
encoded proteins | 67 |
highly pathogenic | 67 |
ii mhc | 67 |
sh domain | 67 |
surface markers | 67 |
encephalomyocarditis virus | 67 |
aqueous solution | 67 |
amino group | 67 |
control groups | 67 |
antigenic determinants | 67 |
expression profile | 67 |
largely unknown | 67 |
protein involved | 67 |
ribosomal subunit | 66 |
terminal domains | 66 |
ordered proteins | 66 |
also play | 66 |
cell development | 66 |
cellular components | 66 |
receptor signaling | 66 |
potent inhibitors | 66 |
healthy individuals | 66 |
new class | 66 |
er lumen | 66 |
sorting signals | 66 |
protein phosphatase | 66 |
correlation spectroscopy | 66 |
clinical signs | 66 |
hydrophobic domain | 66 |
western blots | 66 |
protein forms | 66 |
stress responses | 66 |
conditioned media | 66 |
functional receptor | 66 |
stable isotope | 66 |
protein composition | 66 |
intracellular trafficking | 66 |
linear epitopes | 66 |
healthy volunteers | 66 |
host response | 66 |
influenza hemagglutinin | 66 |
ray scattering | 65 |
polyclonal antibody | 65 |
disease severity | 65 |
human igg | 65 |
often used | 65 |
protein design | 65 |
two domains | 65 |
accessory protein | 65 |
purified using | 65 |
mutant protein | 65 |
associated virus | 65 |
primary antibody | 65 |
solution structure | 65 |
ifitm proteins | 65 |
negative controls | 65 |
protein using | 65 |
model systems | 65 |
protein nsp | 65 |
high specificity | 65 |
ribosomal frameshifting | 65 |
tat protein | 65 |
based approaches | 65 |
predicted using | 65 |
protein trafficking | 65 |
cap structure | 65 |
low affinity | 65 |
complex i | 65 |
fourier transform | 65 |
transgenic tobacco | 65 |
bacterial pathogens | 65 |
secretory granule | 65 |
higher affinity | 65 |
novel approach | 65 |
host interaction | 65 |
preliminary data | 65 |
sars virus | 64 |
sukh superfamily | 64 |
protein array | 64 |
much less | 64 |
transmembrane helices | 64 |
conjugated goat | 64 |
much lower | 64 |
cellular localization | 64 |
surfactant proteins | 64 |
based assay | 64 |
heart disease | 64 |
type protein | 64 |
particular interest | 64 |
antiviral responses | 64 |
localization signals | 64 |
using various | 64 |
hybrid system | 64 |
molecular characterization | 64 |
sarcoma virus | 64 |
culture system | 64 |
peptide arrays | 64 |
er proteins | 64 |
past years | 64 |
interaction map | 64 |
next step | 64 |
golgi membrane | 64 |
protective role | 64 |
novel human | 64 |
morphological changes | 64 |
kinase inhibitor | 64 |
protein networks | 64 |
also investigated | 64 |
membrane permeability | 64 |
electron transfer | 64 |
genetic analysis | 64 |
feline infectious | 64 |
start site | 64 |
viral spike | 64 |
em structure | 64 |
high molecular | 64 |
national institute | 64 |
infectious peritonitis | 64 |
mouse igg | 64 |
cytotoxic effects | 63 |
caenorhabditis elegans | 63 |
protein might | 63 |
positive bacteria | 63 |
results will | 63 |
human body | 63 |
medium containing | 63 |
oral administration | 63 |
bacterial species | 63 |
recently identified | 63 |
intermediate compartment | 63 |
still unknown | 63 |
model membranes | 63 |
membrane binding | 63 |
replicative structures | 63 |
cellular mrnas | 63 |
matrix proteins | 63 |
one protein | 63 |
increasing evidence | 63 |
small size | 63 |
bispecific antibodies | 63 |
human breast | 63 |
blood glucose | 63 |
homologous proteins | 63 |
tobacco plants | 63 |
recently shown | 63 |
genetically modified | 63 |
brain injury | 63 |
plant cell | 63 |
japanese encephalitis | 63 |
domain proteins | 63 |
leucine zipper | 63 |
pp ab | 63 |
wistar rats | 63 |
induces apoptosis | 63 |
host cellular | 63 |
autophagy genes | 63 |
dendritic cell | 63 |
secondary antibodies | 63 |
like domain | 63 |
viral assembly | 62 |
specific immune | 62 |
isoelectric point | 62 |
cho cell | 62 |
proton channel | 62 |
membrane glycoprotein | 62 |
vesicular transport | 62 |
detailed analysis | 62 |
solid support | 62 |
receptor recognition | 62 |
patients suffering | 62 |
bat sars | 62 |
active peptides | 62 |
domain ii | 62 |
ribosome biogenesis | 62 |
mrna decay | 62 |
ros production | 62 |
protein tyrosine | 62 |
cell carcinoma | 62 |
dependent kinase | 62 |
nmr spectra | 62 |
cov replication | 62 |
mice lacking | 62 |
glioma cells | 62 |
electron microscope | 62 |
specific cell | 62 |
fl uorescence | 62 |
membrane surface | 62 |
based assays | 62 |
density lipoprotein | 62 |
nicotiana benthamiana | 62 |
cell protein | 62 |
charged amino | 62 |
kidney cells | 62 |
least three | 62 |
level expression | 62 |
crispr cas | 61 |
toxic effects | 61 |
structural genomics | 61 |
potential use | 61 |
tof tof | 61 |
tissue damage | 61 |
stop codon | 61 |
molecular interaction | 61 |
specific cellular | 61 |
small cell | 61 |
viral surface | 61 |
supplementary data | 61 |
guanine nucleotide | 61 |
protein fragments | 61 |
phylogenetic tree | 61 |
mg dl | 61 |
experimental results | 61 |
among different | 61 |
ifn signaling | 61 |
study provides | 61 |
polymerase activity | 61 |
rat model | 61 |
cyclic peptides | 61 |
chronic inflammatory | 61 |
quantitative proteomic | 61 |
parainfluenza virus | 61 |
whole genome | 61 |
also detected | 61 |
highly efficient | 61 |
derived peptides | 61 |
phase ii | 61 |
pcr products | 61 |
proteins found | 61 |
specific inhibitors | 61 |
endothelial growth | 61 |
heterologous expression | 61 |
coated vesicles | 61 |
extensively studied | 61 |
structural elements | 61 |
associated herpesvirus | 61 |
native structure | 61 |
deletion mutants | 61 |
dna methylation | 61 |
database search | 61 |
bacterial infections | 61 |
neurodegenerative disorders | 61 |
dipeptidyl peptidase | 61 |
showed high | 61 |
negatively regulates | 61 |
last decade | 61 |
relatively low | 61 |
expression data | 60 |
proteins also | 60 |
mediated apoptosis | 60 |
antibody binding | 60 |
vice versa | 60 |
helix bundle | 60 |
click chemistry | 60 |
isolated using | 60 |
glutamic acids | 60 |
rabbit igg | 60 |
gives rise | 60 |
dimensional gel | 60 |
scale production | 60 |
cell lysis | 60 |
activity relationship | 60 |
different levels | 60 |
virus life | 60 |
chemical properties | 60 |
sequence comparison | 60 |
proteins will | 60 |
strand breaks | 60 |
mutational analysis | 60 |
acid substitutions | 60 |
tm domain | 60 |
signal sequences | 60 |
milk protein | 60 |
ph values | 60 |
using high | 60 |
enzyme activities | 60 |
prion protein | 60 |
small intestinal | 60 |
viral load | 60 |
hidden markov | 60 |
campylobacter jejuni | 60 |
human growth | 60 |
training set | 60 |
modifi cation | 60 |
binding residues | 60 |
low cost | 59 |
stationary phase | 59 |
ms data | 59 |
might play | 59 |
one another | 59 |
autophagy proteins | 59 |
provide evidence | 59 |
evolutionarily conserved | 59 |
experiments using | 59 |
severe covid | 59 |
poly i | 59 |
million people | 59 |
intercellular communication | 59 |
findings indicate | 59 |
frog virus | 59 |
nuclear membrane | 59 |
target membrane | 59 |
biochemical characterization | 59 |
host innate | 59 |
regulatory role | 59 |
protein phosphorylation | 59 |
clinical use | 59 |
chain length | 59 |
expressed protein | 59 |
membrane trafficking | 59 |
antigenic sites | 59 |
aromatic residues | 59 |
regulated protein | 59 |
native protein | 59 |
polyethylene glycol | 59 |
using recombinant | 59 |
factor alpha | 59 |
nucleocapsid proteins | 59 |
lateral sclerosis | 59 |
plasma cells | 59 |
type virus | 59 |
human population | 59 |
receptor protein | 59 |
gene family | 59 |
homology models | 59 |
antibody titers | 59 |
signifi cant | 59 |
retinoic acid | 59 |
high yield | 59 |
given protein | 58 |
producing cells | 58 |
xenopus oocytes | 58 |
competing interests | 58 |
interferon response | 58 |
functional significance | 58 |
interferon signaling | 58 |
deep learning | 58 |
major structural | 58 |
may reflect | 58 |
fusion pore | 58 |
fast protein | 58 |
secretory vesicles | 58 |
laser scanning | 58 |
like growth | 58 |
wheat germ | 58 |
autophagy pathway | 58 |
analysis indicated | 58 |
animal viruses | 58 |
phase synthesis | 58 |
previously identified | 58 |
terminal sequence | 58 |
biological membranes | 58 |
hydrophobic core | 58 |
embryonic stem | 58 |
dependent translation | 58 |
near future | 58 |
protein produced | 58 |
specific protease | 58 |
two subunits | 58 |
peptide vaccine | 58 |
viral translation | 58 |
cells grown | 58 |
new drugs | 58 |
adhesion molecule | 58 |
schwann cell | 58 |
may influence | 58 |
ppi network | 58 |
uninfected cells | 58 |
therapeutic applications | 58 |
binding regions | 58 |
patients compared | 58 |
unpublished data | 58 |
acidic ph | 58 |
papillomavirus type | 58 |
cellular membrane | 58 |
rich region | 58 |
protein also | 58 |
phase separation | 57 |
blood plasma | 57 |
lung tissue | 57 |
signal intensity | 57 |
done using | 57 |
lesser extent | 57 |
raman spectroscopy | 57 |
ramachandran plot | 57 |
binding modes | 57 |
murine hepatitis | 57 |
intracellular ca | 57 |
i will | 57 |
i ifns | 57 |
various types | 57 |
genome sequencing | 57 |
results demonstrated | 57 |
golgi cisternae | 57 |
induced autophagy | 57 |
gel filtration | 57 |
avian infectious | 57 |
viral glycoprotein | 57 |
homologous recombination | 57 |
nucleotide exchange | 57 |
glycosylation site | 57 |
amyotrophic lateral | 57 |
main proteinase | 57 |
results provide | 57 |
titration calorimetry | 57 |
neurodegenerative disease | 57 |
ev isolation | 57 |
concentration range | 57 |
phase transition | 57 |
peptide library | 57 |
activity relationships | 57 |
bacillus anthracis | 57 |
protein quality | 57 |
three independent | 57 |
binding assay | 57 |
specific interactions | 57 |
receptor antagonist | 57 |
infectious agents | 57 |
rna polymerases | 56 |
functional proteins | 56 |
identify potential | 56 |
nlrp inflammasome | 56 |
cellular responses | 56 |
technical university | 56 |
deubiquitinating enzyme | 56 |
inkt cells | 56 |
family member | 56 |
recent developments | 56 |
biological samples | 56 |
coding regions | 56 |
intestinal mucosa | 56 |
bacterial cell | 56 |
factors involved | 56 |
domain protein | 56 |
per cell | 56 |
significant effect | 56 |
coding sequences | 56 |
single nucleotide | 56 |
peptide inhibitors | 56 |
kda proteins | 56 |
docking studies | 56 |
normal cells | 56 |
bovine coronavirus | 56 |
precursor protein | 56 |
increasing number | 56 |
inner membrane | 56 |
study shows | 56 |
penetrating peptides | 56 |
also important | 56 |
actin filaments | 56 |
group ii | 56 |
host mrnas | 56 |
dna sequencing | 56 |
vector machine | 56 |
false positive | 56 |
currently used | 56 |
will discuss | 56 |
higher concentrations | 56 |
liver disease | 56 |
recent work | 56 |
allow us | 56 |
gastroenteritis coronavirus | 56 |
pdz domain | 56 |
antibodies directed | 55 |
mortality rate | 55 |
transmembrane region | 55 |
protein subcellular | 55 |
acid metabolism | 55 |
neural stem | 55 |
salmonella typhimurium | 55 |
fat diet | 55 |
uniprot id | 55 |
nk cell | 55 |
th century | 55 |
wt mice | 55 |
specific primers | 55 |
isothermal titration | 55 |
washed twice | 55 |
data showed | 55 |
fast proteins | 55 |
pore formation | 55 |
research council | 55 |
beneficial effects | 55 |
potent inhibitor | 55 |
normal human | 55 |
cell clones | 55 |
antiviral immunity | 55 |
protein database | 55 |
small rnas | 55 |
tissue engineering | 55 |
innate antiviral | 55 |
recently described | 55 |
neutral ph | 55 |
acetic acid | 55 |
corona virus | 55 |
virus budding | 55 |
domain iii | 55 |
lung diseases | 55 |
cell communication | 55 |
two decades | 55 |
using molecular | 55 |
hydrophobic interaction | 55 |
affinity binding | 55 |
cell functions | 55 |
functionally important | 55 |
complex class | 55 |
ms spectra | 55 |
stimulating factor | 55 |
viral attachment | 55 |
small interfering | 55 |
allows us | 55 |
replicase proteins | 55 |
will focus | 54 |
small angle | 54 |
great interest | 54 |
clinical practice | 54 |
various cell | 54 |
next generation | 54 |
potential biomarkers | 54 |
fusion peptides | 54 |
atomic resolution | 54 |
feline coronavirus | 54 |
mediated activation | 54 |
recent data | 54 |
specific dna | 54 |
experiments showed | 54 |
scoring functions | 54 |
major challenge | 54 |
new generation | 54 |
dmcpd bs | 54 |
protein samples | 54 |
higher order | 54 |
environmental conditions | 54 |
autoimmune disease | 54 |
hydrophobic amino | 54 |
relatively small | 54 |
systematic review | 54 |
early diagnosis | 54 |
diseases including | 54 |
two weeks | 54 |
newly developed | 54 |
bacterial cells | 54 |
protein products | 54 |
physiological functions | 54 |
chemical engineering | 54 |
human monoclonal | 54 |
free radical | 54 |
bioinformatics tools | 54 |
binding peptides | 54 |
results revealed | 54 |
common feature | 54 |
lactate dehydrogenase | 54 |
base pairs | 54 |
viral components | 54 |
foxo proteins | 54 |
residues within | 54 |
mrna splicing | 53 |
human pathogens | 53 |
nucleotide sequences | 53 |
ctl epitopes | 53 |
peptides containing | 53 |
congo hemorrhagic | 53 |
financial support | 53 |
potential vaccine | 53 |
coronavirus rna | 53 |
spectrometry analysis | 53 |
control subjects | 53 |
ctl responses | 53 |
method using | 53 |
dynamic range | 53 |
th cells | 53 |
linear epitope | 53 |
cells lacking | 53 |
using nmr | 53 |
experimental studies | 53 |
bl mice | 53 |
ucsf chimera | 53 |
high concentration | 53 |
interfering rna | 53 |
energy function | 53 |
three domains | 53 |
solid state | 53 |
degradation products | 53 |
triple helix | 53 |
two independent | 53 |
adenovirus type | 53 |
based screening | 53 |
receptor expression | 53 |
extracellular space | 53 |
inflammatory bowel | 53 |
damage response | 53 |
fluorescently labeled | 53 |
atp hydrolysis | 53 |
packaging signal | 53 |
trypsin inhibitor | 53 |
enveloped virus | 53 |
proteolytic degradation | 53 |
study revealed | 53 |
pharmaceutical industry | 53 |
gene sequences | 53 |
successfully applied | 53 |
jurkat cells | 53 |
conserved across | 53 |
thermo scientific | 53 |
expression profiling | 53 |
quantified using | 53 |
nucleolar protein | 53 |
see also | 53 |
defense mechanisms | 53 |
phosphate dehydrogenase | 52 |
protein solubility | 52 |
acidic protein | 52 |
fi cation | 52 |
frequently used | 52 |
correct folding | 52 |
three major | 52 |
confocal laser | 52 |
host gene | 52 |
recombinant vaccinia | 52 |
transferrin receptor | 52 |
drug administration | 52 |
molten globule | 52 |
network analysis | 52 |
independent manner | 52 |
patients infected | 52 |
transcriptional activation | 52 |
neuronal cell | 52 |
cellular rna | 52 |
proteins like | 52 |
viral genes | 52 |
binding motifs | 52 |
low level | 52 |
coding genes | 52 |
also tested | 52 |
infrared spectroscopy | 52 |
microglial activation | 52 |
glycan binding | 52 |
therapeutic strategy | 52 |
processes including | 52 |
generation sequencing | 52 |
restriction enzyme | 52 |
optical density | 52 |
tomato leaf | 52 |
embryonic development | 52 |
upstream aug | 52 |
clinical characteristics | 52 |
structure analysis | 52 |
rous sarcoma | 52 |
yersinia pestis | 52 |
like peptide | 52 |
cancer progression | 52 |
also show | 52 |
dna fragments | 52 |
phosphate buffer | 52 |
based prediction | 52 |
fetal bovine | 52 |
different methods | 52 |
avian coronavirus | 52 |
polarized epithelial | 52 |
cellular signaling | 52 |
genome organization | 52 |
terminal fragment | 52 |
three distinct | 52 |
kinase inhibitors | 52 |
urine samples | 52 |
apoptosis induced | 52 |
signaling cascade | 52 |
adrenergic receptor | 52 |
mrna level | 52 |
modifi cations | 52 |
highly selective | 52 |
cytokine storm | 52 |
prediction methods | 52 |
antiviral effects | 52 |
host antiviral | 52 |
living organisms | 51 |
fatty acyl | 51 |
magnetic beads | 51 |
tyrosine phosphorylation | 51 |
ion exchange | 51 |
complement activation | 51 |
promoter activity | 51 |
isotope labeling | 51 |
associated molecular | 51 |
proteins present | 51 |
peptide fragments | 51 |
santa cruz | 51 |
different molecular | 51 |
golgi fragmentation | 51 |
membrane lipid | 51 |
zeta potential | 51 |
potato virus | 51 |
recent evidence | 51 |
human cancer | 51 |
coli bl | 51 |
specific expression | 51 |
covalently linked | 51 |
golgi structure | 51 |
substrate binding | 51 |
various diseases | 51 |
serum protein | 51 |
terminal signal | 51 |
protein interfaces | 51 |
cell proteins | 51 |
unknown function | 51 |
oxidative damage | 51 |
high efficiency | 51 |
protein containing | 51 |
carbonic anhydrase | 51 |
complement system | 51 |
interferon regulatory | 51 |
recombinant dna | 51 |
secretory protein | 51 |
results suggested | 51 |
proteolytic enzymes | 51 |
target sites | 51 |
many years | 51 |
transform infrared | 51 |
see section | 51 |
igg antibody | 51 |
luciferase reporter | 51 |
pharmaceutical proteins | 51 |
cells also | 51 |
pedv infection | 51 |
infected individuals | 51 |
also contains | 51 |
sodium dodecyl | 51 |
molecular function | 51 |
i i | 51 |
coding rnas | 51 |
human cd | 50 |
targeting signal | 50 |
giving rise | 50 |
ray diffraction | 50 |
method based | 50 |
physiological role | 50 |
well defined | 50 |
pharmakologie und | 50 |
rna sequencing | 50 |
developed using | 50 |
virus gene | 50 |
mediated inhibition | 50 |
sequence conservation | 50 |
single stranded | 50 |
electron density | 50 |
salmonella enterica | 50 |
weight loss | 50 |
sample buffer | 50 |
atp binding | 50 |
may function | 50 |
study demonstrates | 50 |
open access | 50 |
small proteins | 50 |
proteomic studies | 50 |
nsp proteins | 50 |
vg vd | 50 |
coronary artery | 50 |
primary antibodies | 50 |
research institute | 50 |
specific manner | 50 |
therapeutic options | 50 |
conformational analysis | 50 |
human umbilical | 50 |
heterologous proteins | 50 |
virus strains | 50 |
common cold | 50 |
hematopoietic stem | 50 |
mhc i | 50 |
blood cell | 50 |
incubated overnight | 50 |
initiation codon | 50 |
nuclear protein | 50 |
response element | 50 |
many studies | 50 |
known protein | 50 |
mitochondrial dysfunction | 50 |
conformational space | 50 |
lipid raft | 50 |
global health | 50 |
obtained results | 50 |
proteins interact | 50 |
surface glycoprotein | 50 |
binding specificity | 50 |
receptor complex | 50 |
cells ml | 50 |
length protein | 50 |
bioinformatics analysis | 50 |
promising approach | 50 |
vitro assays | 50 |
platelet count | 50 |
unnatural amino | 50 |
binding assays | 50 |
internal initiation | 50 |
mitochondrial proteins | 50 |
also contain | 50 |
specific functions | 50 |
tight junction | 50 |
specific ctl | 50 |
functional genomics | 50 |
several viral | 50 |
protein markers | 50 |
tissue samples | 50 |
protein dynamics | 50 |
hsp family | 50 |
live attenuated | 50 |
using specific | 50 |
recent reports | 50 |
cell metabolism | 49 |
neuropathic pain | 49 |
protective effects | 49 |
flight mass | 49 |
humoral immunity | 49 |
reaction monitoring | 49 |
coli cells | 49 |
correlation coefficient | 49 |
effective vaccine | 49 |
chemical shifts | 49 |
enzymatic activities | 49 |
membrane anchor | 49 |
genes proteins | 49 |
ml min | 49 |
antiviral agents | 49 |
gene encodes | 49 |
induce apoptosis | 49 |
phylogenetic trees | 49 |
mouse anti | 49 |
one example | 49 |
carrier protein | 49 |
tg mice | 49 |
golgi compartment | 49 |
protein fold | 49 |
positive correlation | 49 |
cancer stem | 49 |
control mice | 49 |
lymphocytic choriomeningitis | 49 |
scanning microscopy | 49 |
transmembrane helix | 49 |
transfection efficiency | 49 |
induced changes | 49 |
food intake | 49 |
helicase activity | 49 |
factor eif | 49 |
vitro transcription | 49 |
may facilitate | 49 |
immune recognition | 49 |
acyl chains | 49 |
ace microbody | 49 |
disease caused | 49 |
urgent need | 49 |
markov model | 49 |
hcv rna | 49 |
large numbers | 49 |
proteins targeted | 49 |
cancer treatment | 49 |